0.7369
price up icon4.15%   0.0359
 
loading
전일 마감가:
$0.701
열려 있는:
$0.691
하루 거래량:
528.60K
Relative Volume:
0.49
시가총액:
$54.56M
수익:
$11.03M
순이익/손실:
$-44.24M
주가수익비율:
-1.1885
EPS:
-0.62
순현금흐름:
$-42.61M
1주 성능:
-8.49%
1개월 성능:
-24.73%
6개월 성능:
-27.71%
1년 성능:
-24.73%
1일 변동 폭
Value
$0.691
$0.7862
1주일 범위
Value
$0.6797
$0.7977
52주 변동 폭
Value
$0.6797
$1.90

Hyperfine Inc Stock (HYPR) Company Profile

Name
명칭
Hyperfine Inc
Name
전화
866-796-6767
Name
주소
351 NEW WHITFIELD STREET, GUILFORD
Name
직원
111
Name
트위터
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
HYPR's Discussions on Twitter

HYPR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
HYPR
Hyperfine Inc
0.7304 54.56M 11.03M -44.24M -42.61M -0.62
Medical Devices icon
ABT
Abbott Laboratories
131.48 225.32B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.05 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
376.19 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.56 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
71.69 42.10B 5.72B 4.17B 259.90M 6.97

Hyperfine Inc Stock (HYPR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-08-11 다운그레이드 Wells Fargo Overweight → Equal Weight
2022-05-31 개시 Evercore ISI Outperform
2022-04-14 개시 Wells Fargo Overweight

Hyperfine Inc 주식(HYPR)의 최신 뉴스

pulisher
Mar 25, 2025

Lake Street Initiates Coverage of Hyperfine (HYPR) with Buy Recommendation - MSN

Mar 25, 2025
pulisher
Mar 24, 2025

Lake Street starts Hyperfine stock with Buy, sets $1.50 target By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Lake Street starts Hyperfine stock with Buy, sets $1.50 target - Investing.com

Mar 24, 2025
pulisher
Mar 24, 2025

Lake Street Initiates Hyperfine at Buy With $1.50 Price Target -March 24, 2025 at 08:20 am EDT - MarketScreener

Mar 24, 2025
pulisher
Mar 24, 2025

Hyperfine initiated with a Buy at Lake Street - TipRanks

Mar 24, 2025
pulisher
Mar 22, 2025

What You Can Learn From Hyperfine, Inc.'s (NASDAQ:HYPR) P/S After Its 28% Share Price Crash - Simply Wall St

Mar 22, 2025
pulisher
Mar 20, 2025

Hyperfine price target lowered to $1.20 from $1.50 at B. Riley - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

B. Riley Trims Price Target on Hyperfine to $1.20 From $1.50, Keeps Buy Rating -March 20, 2025 at 07:57 am EDT - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

HYPR Stock Price and Chart — NASDAQ:HYPR - TradingView

Mar 20, 2025
pulisher
Mar 19, 2025

Hyperfine, Inc. (NASDAQ:HYPR) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

Hyperfine Inc. Faces Potential Stock Price Decline Amid $150 Million Securities Sale Plan - TipRanks

Mar 19, 2025
pulisher
Mar 18, 2025

Hyperfine Inc. Earnings Call: Growth Amid Challenges - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Hyperfine teams up with NVIDIA to enhance AI-powered portable MR - DOTmed HealthCare Business News

Mar 18, 2025
pulisher
Mar 18, 2025

Hyperfine reports net loss of USD 10.39M in Q4 2024 - Medical Buyer

Mar 18, 2025
pulisher
Mar 18, 2025

Hyperfine Inc (HYPR) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges By GuruFocus - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

NVIDIA partners with Hyperfine on Swoop MRI AI system - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

Earnings call transcript: Hyperfine Q4 2024 reports mixed results By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 17, 2025

Hyperfine, Inc. Reports 2024 Financial Results and Strategic Expansion - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

Earnings call transcript: Hyperfine Q4 2024 reports mixed results - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine earnings matched, revenue fell short of estimates - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine shares tumble as Q4 revenue misses estimates By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine shares tumble as Q4 revenue misses estimates - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

HYPERFINE Earnings Results: $HYPR Reports Quarterly Earnings - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine reports Q4 EPS (14c), consensus (14c) - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation - 01net

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine, NVIDIA Partner to Transform Neuroimaging with AI - MPO-mag

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine Collaborating With Nvidia to Improve Portable MRI Technology; Shares Jump - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine partners with NVIDIA to enhance portable MRI tech - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Hyperfine partners with NVIDIA to enhance portable MRI tech By Investing.com - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

Revolutionary AI Partnership: How Hyperfine and NVIDIA Are Making Brain MRI Available to Billions - StockTitan

Mar 17, 2025
pulisher
Mar 17, 2025

Earnings Scheduled For March 17, 2025 - Benzinga

Mar 17, 2025
pulisher
Mar 10, 2025

Hyperfine (HYPR) Projected to Post Earnings on Monday - Defense World

Mar 10, 2025
pulisher
Mar 04, 2025

When Will Portable MRI Pioneer Hyperfine Reveal Its 2024 Performance? - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 - Business Wire

Mar 04, 2025
pulisher
Feb 20, 2025

Insider Selling: TEISSEYRE THOMAS, Hyperfine Inc [HYPR] Chief Operating Officer divested 3,237 shares - Knox Daily

Feb 20, 2025
pulisher
Feb 18, 2025

Hyperfine COO Thomas Teisseyre sells $3,884 in stock By Investing.com - Investing.com Australia

Feb 18, 2025
pulisher
Feb 18, 2025

Hyperfine COO Thomas Teisseyre sells $3,884 in stock - Investing.com India

Feb 18, 2025
pulisher
Feb 17, 2025

Hyperfine reports growing evidence supporting use of Swoop system images in stroke diagnosis - NeuroNews International

Feb 17, 2025
pulisher
Feb 13, 2025

Hyperfine stock tumbles after direct offering announcement - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

Hyperfine announces registered direct offering - Medical Buyer

Feb 12, 2025
pulisher
Feb 12, 2025

Hyperfine announces $6 million direct offering - MSN

Feb 12, 2025
pulisher
Feb 11, 2025

Hyperfine looks to raise $6M in direct offering, stock tumbles - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Hyperfine Announces $6.0 Million Registered Direct Offering - citybiz

Feb 11, 2025

Hyperfine Inc (HYPR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Hyperfine Inc 주식 (HYPR) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
TEISSEYRE THOMAS
Chief Operating Officer
Nov 18 '24
Sale
0.85
2,800
2,380
88,227
TEISSEYRE THOMAS
Chief Operating Officer
Aug 16 '24
Sale
1.05
2,746
2,883
91,027
TEISSEYRE THOMAS
Chief Operating Officer
May 16 '24
Sale
0.88
2,753
2,423
93,773
medical_devices STE
$227.12
price up icon 0.69%
medical_devices ZBH
$112.20
price down icon 0.15%
medical_devices PHG
$24.82
price down icon 1.68%
$67.68
price up icon 0.74%
$79.18
price down icon 0.49%
medical_devices EW
$71.74
price down icon 0.19%
자본화:     |  볼륨(24시간):